 |
ambrisentan |
|---|---|
| Trade Name | Letairis |
| Orphan Indication | Idiopathic pulmonary fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2009-12-23 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;199 East Blaine Street;Seattle, Washington, 98102 |
| |
ambrisentan |
|---|---|
| Trade Name | Letairis |
| Orphan Indication | Idiopathic pulmonary fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2009-12-23 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;199 East Blaine Street;Seattle, Washington, 98102 |